Tylvalosin-d9 is the deuterium-labeled form of Tylvalosin, a third-generation macrolide with anti-inflammatory properties. It reduces levels of IL-8, IL-6, IL-1β, PGE2, TNF-α, and NO, and decreases inflammatory cell recruitment and activation in a mouse acute lung injury model. This compound can be used as a tracer or an internal standard for quantitative analysis.
- Reduces levels of inflammatory mediators
- Decreases inflammatory cell recruitment and activation
- Functions as a tracer for quantitative analysis
- Functions as an internal standard for techniques like NMR, GC-MS, or LC-MS